EU pushes €12 million into Amsterdam hospital's cancer research

The European Union will spend 12 million euros on research into a potential treatment for lung cancer. A group of international researchers that the Cancer Center Amsterdam is leading are now going to unravel long tumors, the Amsterdam UMC reported, of which the center is a part. They will do that with EU money "to predict which patients are and are not helped by immunotherapy.

This is called project SPACETIME. It involves researching the connection between cancer cells, immune cells, and supporting cells found in tumors. "It is now crystal clear that a tumor is not an aimlessly proliferating clump of cells, but rather an organized mix of cells that interact both inside and outside the tumor," said one of the coordinators, Febe van Maldegem, a researcher at Amsterdam UMC.

SPACETIME will take five years and will be performed by 15 partners in seven European countries.

Amsterdam UMC claims that over 14,500 people hear that they have lung cancer every year.